Analysis of the Antihypertensive Market in Select SADC Countries

Analysis of the Antihypertensive Market in Select SADC Countries

Is There an Opportunity for Growth in the Antihypertensive Market?

RELEASE DATE
25-Sep-2012
REGION
Africa
Research Code: M8A2-01-00-00-00
SKU: HC01990-AF-MR_07240

$6,950.00

Special Price $5,212.50 save 25 %

In stock
SKU
HC01990-AF-MR_07240

$6,950.00

$5,212.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This research service presents the findings on the antihypertensive market in select Southern Africa Developing Countries (SADC). The market size and growth of the total antihypertensive market is provided at total and country level. These give an insight into the major factors that are driving the market, together with main restrains that are limiting growth. The market size and growth for the four main drug classes are also presented both at aggregate and country level. At country level, a brief competitive overview is also provided for the antihypertensive market and this highlights key suppliers in the market and their respective market share. Key products that are top performing for each key supplier are also presented.

Table of Contents

Overview of Key Findings

  • Introduction to Executive Summary

Overview of Total Market

  • Introduction to Total Market Analysis

Overview of Zimbabwe Country Breakdown

  • Introduction to Zimbabwe Country Breakdown

Overview of Malawi Country Breakdown

  • Introduction to Malawi Country Breakdown

Overview of Mauritius Country Breakdown

  • Introduction to Mauritius Country Breakdown

Overview of The Last Words

  • Introduction to The Last Words
Related Research
This research service presents the findings on the antihypertensive market in select Southern Africa Developing Countries (SADC). The market size and growth of the total antihypertensive market is provided at total and country level. These give an insight into the major factors that are driving the market, together with main restrains that are limiting growth. The market size and growth for the four main drug classes are also presented both at aggregate and country level. At country level, a brief competitive overview is also provided for the antihypertensive market and this highlights key suppliers in the market and their respective market share. Key products that are top performing for each key supplier are also presented.
More Information
No Index No
Podcast No
Author Kudzai Moyo
Industries Healthcare
WIP Number M8A2-01-00-00-00
Is Prebook No